Alembic has invested in 1 company and its latest investment was RIGImmune on Dec 10, 2021
FOLLOW STATUS
COMPANY
DESCRIPTION
AMOUNT
INVESTMENT DATE
ROUND
EXIT DATE
RIGImmune is a Connecticut-based biotechnology company that develops and commercializes RNA-based therapies for the treatment of cancer and viral diseases.
